139 related articles for article (PubMed ID: 15471948)
1. The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis.
Xu M; Bruno E; Chao J; Ni H; Lindgren V; Nunez R; Mahmud N; Finazzi G; Fruchtman SM; Popat U; Liu E; Prchal JT; Rondelli D; Barosi G; Hoffman R
Blood; 2005 Feb; 105(4):1699-705. PubMed ID: 15471948
[TBL] [Abstract][Full Text] [Related]
2. Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID mice.
Ishii T; Zhao Y; Sozer S; Shi J; Zhang W; Hoffman R; Xu M
Exp Hematol; 2007 Nov; 35(11):1633-40. PubMed ID: 17764815
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of human hematopoietic repopulating cells mobilized with granulocyte colony-stimulating factor alone versus granulocyte colony-stimulating factor in combination with stem cell factor.
Hess DA; Levac KD; Karanu FN; Rosu-Myles M; White MJ; Gallacher L; Murdoch B; Keeney M; Ottowski P; Foley R; Chin-Yee I; Bhatia M
Blood; 2002 Aug; 100(3):869-78. PubMed ID: 12130497
[TBL] [Abstract][Full Text] [Related]
4. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells.
van der Loo JC; Hanenberg H; Cooper RJ; Luo FY; Lazaridis EN; Williams DA
Blood; 1998 Oct; 92(7):2556-70. PubMed ID: 9746798
[TBL] [Abstract][Full Text] [Related]
5. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.
Murray L; Chen B; Galy A; Chen S; Tushinski R; Uchida N; Negrin R; Tricot G; Jagannath S; Vesole D
Blood; 1995 Jan; 85(2):368-78. PubMed ID: 7529060
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characterization of malignant progenitor cells in patients with idiopathic myelofibrosis.
Bao Y; Hu W; Guo Y; Yang W
Hematol Oncol Stem Cell Ther; 2019 Sep; 12(3):146-154. PubMed ID: 30796884
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
8. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.
Hess DA; Bonde J; Craft TP; Wirthlin L; Hohm S; Lahey R; Todt LM; Dipersio JF; Devine SM; Nolta JA
Biol Blood Marrow Transplant; 2007 Apr; 13(4):398-411. PubMed ID: 17382247
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice.
Schiedlmeier B; Kühlcke K; Eckert HG; Baum C; Zeller WJ; Fruehauf S
Blood; 2000 Feb; 95(4):1237-48. PubMed ID: 10666196
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony-stimulating factor mobilizes into peripheral blood the complete clonal repertoire of hematopoietic precursors residing in the bone marrow of mice.
Varas F; Bernad A; Bueren JA
Blood; 1996 Oct; 88(7):2495-501. PubMed ID: 8839841
[TBL] [Abstract][Full Text] [Related]
11. Efflux of CD34+ cells from bone marrow to peripheral blood is selective in steady-state hematopoiesis and during G-CSF administration.
Steen R; Tjønnfjord GE; Gunnes Grøseth LA; Heldal D; Egeland T
J Hematother; 1997 Dec; 6(6):563-73. PubMed ID: 9483191
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of engraftment of CD34(-) and CD34(+) cells from mobilized blood differs from that of CD34(-) and CD34(+) cells from bone marrow.
Verfaillie CM; Almeida-Porada G; Wissink S; Zanjani ED
Exp Hematol; 2000 Sep; 28(9):1071-9. PubMed ID: 11008020
[TBL] [Abstract][Full Text] [Related]
13. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment.
van Hennik PB; de Koning AE; Ploemacher RE
Blood; 1999 Nov; 94(9):3055-61. PubMed ID: 10556189
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
[TBL] [Abstract][Full Text] [Related]
15. Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.
Plett PA; Frankovitz SM; Wolber FM; Abonour R; Orschell-Traycoff CM
Exp Hematol; 2002 Sep; 30(9):1061-9. PubMed ID: 12225798
[TBL] [Abstract][Full Text] [Related]
16. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood.
Zhang XB; Li K; Fok TF; Li CK; James AE; Lam AC; Lee SM; Yuen PM
Bone Marrow Transplant; 2002 Nov; 30(9):557-64. PubMed ID: 12407429
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic capability of CD34+ cord blood cells: a comparison with CD34+ adult bone marrow cells.
Ueda T; Yoshida M; Yoshino H; Kobayashi K; Kawahata M; Ebihara Y; Ito M; Asano S; Nakahata T; Tsuji K
Int J Hematol; 2001 Jun; 73(4):457-462. PubMed ID: 11503959
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow.
Steen R; Tjønnfjord GE; Egeland T
J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606
[TBL] [Abstract][Full Text] [Related]
19. Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents.
Wang X; Zhang W; Ishii T; Sozer S; Wang J; Xu M; Hoffman R
Cancer Res; 2009 Oct; 69(19):7612-8. PubMed ID: 19752087
[TBL] [Abstract][Full Text] [Related]
20. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
